NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

I don’t think that’s unreasonable, Horse. Given how slow the process moves and hardly anything gets done in December, I just can’t see a UK approval this year. But perhaps there’s that 25% chance.

If there’s going to be an ASM, that will need to be driven by the journal article — whenever that happens. I was bummed because I have to travel in September and thought I’d miss the ASM. But the ASM is now likely October at the earliest.